Inhibikase Therapeutics Inc IKT:NASDAQ

RT Quote | NASDAQ | USD
Last | 08/05/22 EDT
0.8161quote price arrow down-0.005 (-0.6135%)
Volume
23,978
52 week range
0.60 - 2.54
Loading...
  • Open0.823
  • Day High0.8307
  • Day Low0.808
  • Prev Close0.81
  • 52 Week High2.54
  • 52 Week High Date09/09/21
  • 52 Week Low0.60
  • 52 Week Low Date05/20/22

Key Stats

  • Market Cap20.59M
  • Shares Out25.23M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-44.9

KEY STATS

  • Open0.823
  • Day High0.8307
  • Day Low0.808
  • Prev Close0.81
  • 52 Week High2.54
  • 52 Week High Date09/09/21
  • 52 Week Low0.60
  • 52 Week Low Date05/20/22
  • Market Cap20.59M
  • Shares Out25.23M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-44.9

RATIOS/PROFITABILITY

  • EPS (TTM)-0.78
  • P/E (TTM)-1.05
  • Fwd P/E (NTM)-1.51
  • EBITDA (TTM)-16.781M
  • ROE (TTM)-79.86%
  • Revenue (TTM)1.74M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-965.21%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/15/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Inhibikase Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is focused on developing therapeutics for Parkinson’s Disease (PD) and related disorders that arise inside and outside of the brain. The Company's product candidates include IkT-148009, IkT-001Pro and IKT-01427. Its lead product candidate, IkT-148009 is a brain penetrant Abelson tyrosine kinase (c-Abl) inhibitor, that halts disease progression and reverses functional loss in the brain and...
Address
3350 Riverwood Parkway Se, Suite 1900
Atlanta, GA
30339
United States

Top Peers

SYMBOLLASTCHG%CHG
TTNP
Titan Pharmaceuticals Inc
1.46+0.01+0.69%
CYTH
Cyclo Therapeutics Inc
2.27+0.02+0.89%
ACER
Acer Therapeutics Inc
1.44+0.01+0.70%
AGTC
Applied Genetic Technologies Corp
0.3841-0.0074-1.8902%
ABVC
ABVC Biopharma Inc
0.6342-0.0395-5.8631%